Please go to the PowerPak homepage
and select a course.
Hepatitis C Update:
2017 Insights for Specialty Pharmacists
Provided by The University of Tennessee College of Pharmacy, in cooperation with ASiM.
Supported by educational grants from Merck & Co Inc.
Since its official identification in 1989, the hepatitis C virus (HCV) has grown from relative obscurity to the most commonly transmitted blood-borne pathogen in the world. In the United States, current estimates indicate that approximately 4.6 million people have antibodies against HCV, and 3.5 million patients are chronically infected. Despite a stable disease rate, the direct healthcare costs for treating patients with HCV are expected to increase from $6.5 billion per year at present to nearly $10 billion per year within the next decade. This archived live symposium will highlight new and emerging opportunities for individualizing HCV treatment and management based on drug efficacy and safety, disease-related factors, patient comorbidities, and other considerations. Pharmacist-led strategies for supporting treatment adherence, navigating cost issues, and ensuring optimal patient outcomes in the era of attainable HCV therapies will be reviewed.
Specialty pharmacists will gain an improved understanding of evidence-based options for individualizing HCV treatment, as well as strategies for improving medication access, adherence, and safety, thus optimizing pharmaceutical care.
This activity is designed for managed care and specialty pharmacists. No prerequisites required.
The University of Tennessee College of Pharmacy takes responsibility for the content, quality, and scientific integrity of this CPE activity. At the conclusion of this activity, the participant should be able to:
- ANALYZE efficacy and safety of novel oral HCV antivirals and future regimens.
- RECOGNIZE the impact comorbid conditions have on HCV therapeutic decision making.
- IMPLEMENT individualized treatment plans for HCV treatment and associated monitoring parameters.
- APPLY strategies to assist patients overcome social and logistical barriers to increase patient adherence.
CREDIT DESIGNATION STATEMENT
The University of Tennessee College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Successful completion of this knowledge-based program will provide a statement for 1.5 contact hours of credit (0.15 CEUs) and will be available at the completion of the activity. Successfully completing the activity and receiving credit includes: 1) attending the session; 2) watching, listening to, and participating in the educational activity; 3) completing the self-assessment instrument with a score of at least 70%. UAN: 0064-0000-17-208-H01-P. CE credit will be submitted to the NABP CPE Monitor within 30 days. It is recommended that you check your NABP CPE Monitor e-profile database 30 days after the completion of any CE activity to ensure that your credits are posted.
NABP e-PROFILE ID NUMBER: Pharmacists or pharmacy technicians with questions regarding their NABP e-Profile or CPE Monitor should refer to the FAQ section on the NABP website: https://nabp.pharmacy/cpe-monitor-service/cpe-monitor-faqs/. To receive credit for your participation in this activity, all pharmacists must include their NABP e-Profile ID number, along with their month and date of birth. If incorrect information is provided, this will result in "rejected" status from the CPE Monitor. It is the responsibility of the participant to notify The University of Tennessee (within the 60 day submission timeframe) of their corrected information. Otherwise, the completed CE will not be accepted by the CPE Monitor.
Please allow up to 30 days for your credit to appear on CPE Monitor.
Type of Activity: Knowledge
Published: August 1, 2017
Expires: August 1, 2018
Fee Information: There is no fee for this educational activity.
Estimated time to complete activity: 90 minutes
HOW TO EARN CREDIT
Participants must complete the activity as described above in the Credit Designation Statement. To answer the questions, click on your selected choice for each answer then proceed to the next question. We recommend that you print a copy of your answers before you submit them to us. Once completed, click on Submit Post-test at the bottom of the page. Your post-test will automatically be graded. If you successfully complete the post-test (score of 70% or higher), your statement of CE credit will be made available immediately. Click on View Certificate and print the CE statement for your records. If you receive a score lower than 70%, you will receive a message notifying you that you did not pass the post-test. You will have 2 opportunities to pass the post-test.
FULL DISCLOSURE POLICY AFFECTING CPE ACTIVITIES
As an accredited provider by the Accreditation Council for Pharmacy Education (ACPE), it is the policy of The University of Tennessee College of Pharmacy to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Course Director and Participating Faculty reported the following:
Pamela S. Belperio PharmD, BCPS, AAHIVP
National Public Health Clinical Pharmacy Specialist
Public Care Services/Population Health
Department of Veterans Affairs
Los Angeles, California
Dr Belperio reports having no relevant financial or advisory relationships with corporate organizations related to this activity.
Eric Sredzinski, PharmD, AAHIVP
EVP, Clinical Affairs and Quality Assurance
Pharmacy Program Director, ADAP
Avella Specialty Pharmacy
Dr Sredzinski reports having no relevant financial or advisory relationships with corporate organizations related to this activity.
OFF-LABEL PRODUCT DISCUSSION
In accordance with ACPE Criteria for Quality, the audience is advised that authors in this CPE activity may include reference(s) to unlabeled, unapproved, or investigational uses of therapeutic agents or biomedical devices. The authors will inform the reader of when they discuss or reference an unapproved, unlabeled, or investigational use of therapeutic agent or biomedical device.
The opinions and recommendations expressed by faculty and other experts whose input is included in this activity are their own. This activity is produced for educational purposes only. Use of The University of Tennessee College of Pharmacy name implies review of educational format, design, and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients.
A participant, sponsor, faculty member, or other individual wanting to file a grievance with respect to any aspect of an activity sponsored or cosponsored by The University of Tennessee College of Pharmacy may contact the Associate Dean for Continuing Education in writing at email@example.com. The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level review.
The following is an archived live symposium designed to help you gauge your basic knowledge of the topic and then direct you to areas you may need to focus on. It consists of 3 sections: an unaccredited pre-test, an interactive case study, and a CPE post-test, and evaluation. All 3 sections must be completed to receive CPE credit. A statement of credit will be available online immediately following successful completion of the activity.
REQUIRED COMPUTER HARDWARE/SOFTWARE
Please ensure the computer you plan to use meets the following minimum requirements:
- Operating System: Windows 98 or higher & Macintosh 2.2 or higher
- Internet Browser (Mac &/Windows): Internet Explorer 6.0 or higher, Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher & Opera 5 or higher
- Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
- Peripherals: Computer speakers or headphones
- Monitor Screen Resolution: 320 x 480 or higher
- Media Viewing Requirements: Adobe Reader, Microsoft Powerpoint, Flash Player & HTML5
TABLE OF CONTENTS*
- Overview of HCV Treatment
- Specialty Pharmacy Implications
- Applications to Practice: Improving Adherence
- HCV Regimens: Individualizing Treatment and Key Monitoring Parameters
- New Regimens
*All presentations are given by both Participating Faculty members.
What you are about to see is a previously recorded live symposium. Please note that only "home study" credit will be awarded for participating in this archived symposium. No "live" credits are available.